Winway Health Desk
Theranos founder Elizabeth Holmes may seek ‘mental disease’ defense in trial,...
Theranos founder and former CEO Elizabeth Holmes
Elizabeth Holmes, the founder and former CEO of defunct blood-testing company Theranos who will be tried in March...
Covid-19 shows primary care’s value to diverse communities and how to...
If Covid-19 has a silver lining for healthcare, it is the light it shines on the value of primary care. On the front lines...
3 ways to bring telehealth to the next level
If there is any type of silver lining for the Covid-19 pandemic – it’s telehealth. According to the Department of Health and Human Services...
Pfizer, Novartis and others return to Facebook after hate speech boycott,...
Pharma marketers including Pfizer, Novartis and AbbVie ditched Facebook advertising in July as part of an initiative to pressure the platform to make changes against...
FDA leaders, facing doubts over the agency’s independence, pledge to ‘follow...
After a series of controversial decisions by the FDA so far in the COVID-19 pandemic, questions have circled over whether politics are entering the agency's...
Roche’s Ocrevus touts 2-year switching data in jam-packed—and growing—multiple sclerosis market
Roche's Ocrevus has seen astronomical growth to the top of the sales leaderboard in an increasingly busy multiple sclerosis market. With its biggest competitors...
AstraZeneca changes minds at NICE, winning Tagrisso coverage in 2 lung...
Despite Tagrisso rapidly establishing itself as the new standard of care for EGFR-mutated non-small cell lung cancer, its maker AstraZeneca has had a hard...
Eli Lilly, squaring off against AbbVie and Biohaven, touts data showing...
With several new acute migraine treatments vying for market share, Eli Lilly is touting new data on Reyvow showing the med can provide patients “pain freedom” in as little as...
Cigna to offer ACA marketplace plans in 79 new counties
Cigna will substantially increase its ACA marketplace footprint next year. The insurer plans to offer plans in 220 counties across 10 states, an increase...
China’s Junshi hits immuno-oncology milestone with breakthrough designation from FDA
U.S. regulators have given a breakthrough therapy designation to an immunotherapy drug for cancers under development by a company in China.
Shanghai-based Junshi Biosciences said...
